Large hepatocellular carcinomas: treatment with transarterial chemoembolization alone or in combination with percutaneous cryoablation

References

• McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19:223–238.
   PubMed Web of Science ®Google Scholar
• Marcon P, Tovo CV, Kliemann DA, et al. Incidence of hepatocellular carcinoma in patients with chronic liver disease due to hepatitis B or C and coinfected with the human immunodeficiency virus: a retrospective cohort study. World J Gastroenterol. 2018;24:613–622.
   PubMed Web of Science ®Google Scholar
• Ke S, Ding X, Gao J, et al. Solitary huge hepatocellular carcinomas 10 cm or larger may be completely ablated by repeated radiofrequency ablation combined with chemoembolization: Initial experience with 9 experience with 9 patients. Mol Med Rep. 2012;5:832–836.
   PubMed Web of Science ®Google Scholar
• Xue T, Le F, Chen R, et al. Transarterial chemoembolization for huge hepatocellular carcinoma with diameter over ten centimeters: a large cohort study. Med Oncol. 2015;32:64.
   PubMed Web of Science ®Google Scholar
• Ariizumi S, Kotera Y, Takahashi Y, et al. Impact of hepatectomy for huge solitary hepatocellular carcinoma. J Surg Oncol. 2013;107:408–413.
   PubMed Web of Science ®Google Scholar
• Yamashita Y, Taketomi A, Shirabe K, et al. Outcomes of hepatic resection for huge hepatocellular carcinoma (≥10 cm in diameter)). J Surg Oncol. 2011;104:292–298.
   PubMed Web of Science ®Google Scholar
• Bartolozzi C, Lencioni R, Caramella D, et al. Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization. Radiology. 1995;197:812–818.
   PubMed Web of Science ®Google Scholar
• Fan J, Tang ZY, Yu YQ, et al. Improved survival with resection after transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma. Dig Surg. 1998;15:674–678.
   PubMed Web of Science ®Google Scholar
• Poon RT, Ngan H, Lo CM, et al. Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol. 2000;73:109–114.
   PubMed Web of Science ®Google Scholar
• Zangos S, Eichler K, Balzer JO, et al. Large-sized hepatocellular carcinoma (HCC): a neoadjuvant treatment protocol with repetitive transarterial chemoembolization (TACE) before percutaneous MR-guided laser-induced thermotherapy (LITT). Eur Radiol. 2007;17:553–563.
   PubMed Web of Science ®Google Scholar
• Littrup PJ, Freeman-Gibb L, Andea A, et al. Cryotherapy for breast fibroadenomas. Radiology. 2005;234:63–72.
   PubMed Web of Science ®Google Scholar
• Sabel MS. Cryo-immunology: a review of the literature and proposed mechanisms for stimulatory versus suppressive immune responses. Cryobiology. 2009;58:1–11.
   PubMed Web of Science ®Google Scholar
• Ladd AP, Rescorla FJ, Baust JG, et al. Cryosurgical effects on growing vessels. Am Surg. 1999;65:677–682.
   PubMed Web of Science ®Google Scholar
• Arciero CA, Sigurdson ER. Liver-directed therapies for patients with primary liver cancer and hepatic metastases. Curr Treat Options in Oncol. 2006;7:399–409.
   PubMedGoogle Scholar
• Niu L, Li J, Xu K. Percutaneous cryoablation for liver cancer. JCTH. 2014;2:182–188.
   Google Scholar
• Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015;61:1579–1590.
   PubMed Web of Science ®Google Scholar
• Wong WS, Patel SC, Cruz FS, et al. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer. 1998;82:1268–1278.
   PubMed Web of Science ®Google Scholar
• Niu LZ, Li JL, Xu KC. Percutaneous cryoablation for liver cancer. J Clin Transl Hepatol. 2014;2:182–188.
   PubMedGoogle Scholar
• Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002;137:1332–1339. 1340.
   PubMedGoogle Scholar
• Alnaggar M, Niu L, Li J, et al. Cryoprotective therapy for huge hepatocellular carcinoma: a study of 14 patients with a single lesion. Cryobiology. 2014;69:457–461.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu Y, Wang C, et al. Cryotherapy is associated with improved clinical outcomes of sorafenib therapy for advanced hepatocellular carcinoma. Cell Biochem Biophys. 2012;63:159–169.
   PubMed Web of Science ®Google Scholar
• Xu KC, Niu LZ, He WB, et al. Percutaneous cryoablation in combination with ethanol injection for unresectable hepatocellular carcinoma. WJG. 2003;9:2686–2689.
   PubMed Web of Science ®Google Scholar
• Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Fan W, Wang Y, et al. Sorafenib with and without transarterial chemoembolization for advanced hepatocellular carcinoma with main portal vein tumor thrombosis: a retrospective analysis. Oncologist. 2015;20:1417–1424.
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30:052–060.
   PubMed Web of Science ®Google Scholar
• Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–181.
   PubMed Web of Science ®Google Scholar
• Hu KQ. Advances in clinical application of cryoablation therapy for hepatocellular carcinoma and metastatic liver tumor. J Clin Gastroenterol. 2014;48:830–836.
   PubMed Web of Science ®Google Scholar
• Xu KC, Niu LZ, Zhou Q, et al. Sequential use of transarterial chemoembolization and percutaneous cryosurgery for hepatocellular carcinoma. WJG. 2009;15:3664–3669.
   PubMed Web of Science ®Google Scholar
• Huang KB, WZ, Fan YY, Zhang Y, et al. Transarterial chemoembolization combined with cryoablation for unresectable large hepatocellular carcinoma: a controlled study. Zhonghua Yi Xue Za Zhi. 2016;96:2978–2982.
   PubMedGoogle Scholar
• Huang M, Wang X, Bin H. Effect of transcatheter arterial chemoembolization combined with argon-helium cryosurgery system on the changes of NK cells and T cell subsets in peripheral blood of hepatocellular carcinoma patients. Cell Biochem Biophys. 2015;73:787–792.
   PubMed Web of Science ®Google Scholar
• Seifert JK, France MP, Zhao J, et al. Large volume hepatic freezing: association with significant release of the cytokines interleukin-6 and tumor necrosis factor a in a rat model. World J Surg. 2002;26:1333–1341.
   PubMed Web of Science ®Google Scholar
• Long XA, Zeng J, Niu L, et al. Alleviating the pain of unresectable hepatic tumors by percutaneous cryoablation: experience in 73 patients. Cryobiology. 2013;67:369–373.
   PubMed Web of Science ®Google Scholar